Celcuity Inc. Cash Flow Statement
CELC / Health Care|9 years of annual SEC 10-K data (FY2016-FY2024)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 9 fiscal years. All figures from audited SEC 10-K filings.
Celcuity Inc. used $83M in operating cash flow and negative free cash flow of $84M in FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$111.8M | -$63.8M | -$40.4M | -$29.6M | -$9.5M | -$7.4M | -$7.5M | -$6.3M | -$3.3M |
| Depreciation & Amortization | $129.9K | $142.8K | $210.9K | $303.2K | $385.6K | $339.0K | $223.0K | $104.7K | $73.1K |
| Operating Cash Flow | -$83.5M | -$53.8M | -$36.0M | -$20.3M | -$7.1M | -$6.0M | -$6.1M | -$4.9M | -$2.9M |
| Capital Expenditures | $249.9K | $97.6K | $158.8K | $81.9K | $89.4K | -$380.2K | $629.6K | $239.8K | $40.9K |
| Free Cash Flow | -$83.7M | -$53.9M | -$36.2M | -$20.4M | -$7.2M | -$6.4M | -$6.7M | -$5.2M | -$2.9M |